M. Grubert
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 4
-
- Melanoma and MAPK Pathways 2
- Co-authors
- Heike Richly (11 shared papers)Ralf A. Hilger (10 shared papers)Dirk Strumberg (6 shared papers)M. E. Scheulen (11 shared papers)P. Kupsch (4 shared papers)E. Brendel (3 shared papers)O. Christensen (3 shared papers)Matthias Ludwig (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)European Journal of Cancer (2 papers)Annals of Oncology (1 paper)International Journal of Clinical Pharmacology and Therapeutics (8 papers)
- Partner nations
- GermanyUnited StatesRussia
In The Last Decade
M. Grubert
13 papers receiving 357 citations
Peers
Comparison fields: 5 of 68
- Hepatology 82
- Oncology 163
- Pathology and Forensic Medicine 69
- Cancer Research 44
- Pulmonary and Respiratory Medicine 85
Countries citing papers authored by M. Grubert
This map shows the geographic impact of M. Grubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Grubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Grubert more than expected).
Fields of papers citing papers by M. Grubert
This network shows the impact of papers produced by M. Grubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Grubert. The network helps show where M. Grubert may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Grubert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 119 | |
| 2 | 2008 | 68 | |
| 3 | 2004 | 44 | |
| 4 | 2009 | 31 | |
| 5 | 2009 | 30 | |
| 6 | 2003 | 21 | |
| 7 | 2005 | 18 | |
| 8 | 2017 | 11 | |
| 9 | 2009 | 8 | |
| 10 | 2003 | 6 | |
| 11 | 2012 | 3 | |
| 12 | 2005 | 2 | |
| 13 | 2002 | 1 |
About M. Grubert
M. Grubert is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Biomaterials and Organic Chemistry, having authored 13 papers that have together received 362 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Electron Spin Resonance Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), Melanoma and MAPK Pathways (2 papers), Lanthanide and Transition Metal Complexes (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Hepatology (82 citations), Oncology (163 citations), Pathology and Forensic Medicine (69 citations), Cancer Research (44 citations) and Pulmonary and Respiratory Medicine (85 citations). M. Grubert has collaborated with scholars based in Germany, United States and Russia. Frequent co-authors include Heike Richly, Ralf A. Hilger, Dirk Strumberg, M. E. Scheulen, P. Kupsch, E. Brendel, O. Christensen, Matthias Ludwig, R. Voigtmann and Brian Schwartz. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology and International Journal of Clinical Pharmacology and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.